GSK (NYSE:GSK) Updates FY 2024 Earnings Guidance
MarketBeatGSK (NYSE:GSK) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.710-1.740 for the period, compared to the consensus estimate of 4.060. The company also issued revenue guidance of $40.9 billionillion-$41.7 billionillion, …